These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Rojas L; Martínez-Cuadrón D; Hervás D; Boluda B; García-Robles A; Rodríguez-Veiga R; Martín-Cerezuela M; Cervera J; Sendra L; Sanz J; Miguel A; Lorenzo I; Poveda JL; Sanz MÁ; Aliño SF Leuk Lymphoma; 2017 May; 58(5):1197-1206. PubMed ID: 27701910 [TBL] [Abstract][Full Text] [Related]
29. Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia. Müller-Tidow C; Tschanter P; Röllig C; Thiede C; Koschmieder A; Stelljes M; Koschmieder S; Dugas M; Gerss J; Butterfaß-Bahloul T; Wagner R; Eveslage M; Thiem U; Krause SW; Kaiser U; Kunzmann V; Steffen B; Noppeney R; Herr W; Baldus CD; Schmitz N; Götze K; Reichle A; Kaufmann M; Neubauer A; Schäfer-Eckart K; Hänel M; Peceny R; Frickhofen N; Kiehl M; Giagounidis A; Görner M; Repp R; Link H; Kiani A; Naumann R; Brümmendorf TH; Serve H; Ehninger G; Berdel WE; Krug U; Leukemia; 2016 Mar; 30(3):555-61. PubMed ID: 26522083 [TBL] [Abstract][Full Text] [Related]
30. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients. Jackson K; Kennedy G; Mollee P; Marlton P; Morris K Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966 [TBL] [Abstract][Full Text] [Related]
31. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer. Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537 [TBL] [Abstract][Full Text] [Related]
32. Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines. Specchia G; Buquicchio C; Pansini N; Di Serio F; Liso V; Pastore D; Greco G; Ciuffreda L; Mestice A; Liso A J Lab Clin Med; 2005 Apr; 145(4):212-20. PubMed ID: 15962840 [TBL] [Abstract][Full Text] [Related]
33. CLAG-based induction therapy in previously untreated high risk acute myeloid leukemia patients. Seiter K; Ahmed N; Shaikh A; Baskind P; Liu D Leuk Res; 2016 Jul; 46():74-8. PubMed ID: 27151544 [TBL] [Abstract][Full Text] [Related]
34. The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy. Rybka J; Butrym A; Wróbel T; Jaźwiec B; Stefanko E; Dobrzyńska O; Poręba R; Kuliczkowski K Leuk Res; 2015 Mar; 39(3):318-22. PubMed ID: 25624047 [TBL] [Abstract][Full Text] [Related]
35. The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy. Yanada M; Okamoto A; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Okamoto M; Emi N Int J Hematol; 2015 Jul; 102(1):35-40. PubMed ID: 25822047 [TBL] [Abstract][Full Text] [Related]
36. Evolving Therapies in Acute Myeloid Leukemia: Progress at Last? DeAngelo DJ; Stein EM; Ravandi F Am Soc Clin Oncol Educ Book; 2016; 35():e302-12. PubMed ID: 27249736 [TBL] [Abstract][Full Text] [Related]
37. [Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine]. Goto T; Tanimoto K; Ishibashi M; Okamura S Gan To Kagaku Ryoho; 2012 Aug; 39(8):1227-32. PubMed ID: 22902447 [TBL] [Abstract][Full Text] [Related]
38. HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia. Hu X; Fu W; Wang L; Gao L; Lü S; Xi H; Qiu H; Chen L; Chen J; Ni X; Xu X; Zhang W; Yang J; Wang J; Song X Oncotarget; 2016 Jan; 7(3):3623-34. PubMed ID: 26497216 [TBL] [Abstract][Full Text] [Related]
39. Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better? Campuzano-Zuluaga G; Deutsch Y; Salzberg M; Gomez A; Vargas F; Elias R; Kwon D; Goodman M; Ikpatt OF; Chapman JR; Watts J; Vega F; Swords R Am J Hematol; 2016 Mar; 91(3):277-82. PubMed ID: 26663264 [TBL] [Abstract][Full Text] [Related]
40. Need for routine examination of left ventricular ejection fraction in patients with AML. Khan HM; Gardner KM; Shaw C; Halpern AB; Huebner EM; Percival MM; Mirahsani S; Sorror ML; Becker PS; Walter RB; Estey EH Leukemia; 2020 Apr; 34(4):1169-1171. PubMed ID: 31719680 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]